Cvs Health earnings were $4.5B for the trailing 12 months ending Jun 30, 2025, with -36.2% growth year over year. The latest CVS earnings report on Jun 30, 2025 announced Q2 2025 earnings of $1.0B, down 42.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CVS reported annual earnings of $4.6B, with -44.7% growth.
CVS past earnings growth
How has CVS's earnings growth performed historically?
On CVS's earnings call on Invalid Date, Cvs Health (NYSE: CVS) reported Q2 2025 earnings per share (EPS) of $0.81, up 42.55% year over year. Total CVS earnings for the quarter were $1.02 billion. In the same quarter last year, Cvs Health's earnings per share (EPS) was $1.41.
As of the last Cvs Health earnings report, Cvs Health is currently profitable. Cvs Health's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $4.53 billion, a 36.98% decrease year over year.
What was CVS's earnings growth in the past year?
As of Cvs Health's earnings date in Invalid Date, Cvs Health's earnings has grown -36.17% year over year. This is 58.51 percentage points lower than the US Healthcare Plans industry earnings growth rate of 22.34%. CVS earnings in the past year totalled $4.53 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.